SANA -Sana Biotechnology, Inc.

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=SANA #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

SANA — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

22.58

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

EPS Last/This Y

0.37

EPS This/Next Y

-0.02

Price

3.16

Target Price

8.43

Analyst Recom

1.22

Performance Q

-22.41

Upside

-504.4%

Beta

2.24

Ticker: SANA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	SANA	3.34	0.12	0.47	35149
2026-03-10	SANA	3.3	0.12	0.07	35224
2026-03-11	SANA	3.15	0.12	0.10	35231
2026-03-12	SANA	3.1	0.12	0.20	35166
2026-03-13	SANA	3.09	0.12	0.20	35166
2026-03-17	SANA	3.22	0.12	0.02	35604
2026-03-18	SANA	3.12	0.12	0.17	35591
2026-03-19	SANA	3.17	0.12	0.63	35647
2026-03-20	SANA	3.12	0.12	0.72	35857
2026-03-23	SANA	3.11	0.13	0.00	30730
2026-03-24	SANA	2.92	0.12	0.08	30942
2026-03-25	SANA	3.11	0.12	0.40	31120
2026-03-26	SANA	3.05	0.13	0.69	31335
2026-03-27	SANA	2.78	0.13	0.01	31516
2026-03-30	SANA	2.67	0.13	0.27	31372
2026-03-31	SANA	2.88	0.12	0.07	31181
2026-04-01	SANA	3.05	0.12	0.08	31271
2026-04-02	SANA	3.2	0.12	0.00	31305
2026-04-06	SANA	3.22	0.12	0.31	30983
2026-04-07	SANA	3.16	0.13	0.13	31253
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	SANA	3.34	15.0	29.1	-0.68
2026-03-10	SANA	3.30	15.0	52.0	-0.68
2026-03-11	SANA	3.15	15.0	57.1	-0.68
2026-03-12	SANA	3.10	15.0	52.6	-0.68
2026-03-13	SANA	3.37	26.7	35.7	-0.59
2026-03-17	SANA	3.23	26.7	51.8	-0.59
2026-03-18	SANA	3.12	26.7	123.7	-0.59
2026-03-19	SANA	3.17	26.7	47.3	-0.59
2026-03-20	SANA	3.11	26.7	53.0	-0.59
2026-03-23	SANA	3.11	26.7	50.3	-0.59
2026-03-24	SANA	2.92	26.7	60.2	-0.59
2026-03-25	SANA	3.11	26.7	38.7	-0.59
2026-03-26	SANA	3.05	26.7	52.4	-0.59
2026-03-27	SANA	2.78	26.7	64.3	-0.59
2026-03-30	SANA	2.67	26.7	55.5	-0.59
2026-03-31	SANA	2.87	26.7	37.4	-0.59
2026-04-01	SANA	3.06	26.7	38.9	-0.59
2026-04-02	SANA	3.21	26.7	41.0	-0.59
2026-04-06	SANA	3.22	26.7	48.8	-0.59
2026-04-07	SANA	3.16	26.7	52.9	-0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	SANA	0.00	-2.20	22.43
2026-03-10	SANA	0.00	-2.20	22.43
2026-03-11	SANA	0.00	-2.20	21.56
2026-03-12	SANA	0.00	-2.20	21.56
2026-03-13	SANA	0.00	-2.20	21.56
2026-03-17	SANA	0.00	-2.24	21.56
2026-03-18	SANA	0.00	-2.24	21.56
2026-03-19	SANA	0.00	-2.24	21.56
2026-03-20	SANA	0.00	-2.24	21.56
2026-03-23	SANA	0.00	-2.24	21.56
2026-03-24	SANA	0.00	-2.24	21.56
2026-03-25	SANA	0.00	-2.24	22.58
2026-03-26	SANA	0.00	-2.24	22.58
2026-03-27	SANA	0.00	-2.24	22.58
2026-03-30	SANA	0.00	-2.24	22.58
2026-03-31	SANA	0.00	-2.24	22.58
2026-04-01	SANA	0.00	-2.24	22.58
2026-04-02	SANA	0.00	-2.24	22.58
2026-04-06	SANA	0.00	-2.25	22.58
2026-04-07	SANA	0.00	-2.25	22.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=SANA 589 360 ]

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

Institutional Transactions

-2.25

Beta

2.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.3

Max Drawdown 5-Year %

-95.8

Target Price

8.43

P/E

Forward P/E

PEG

P/S

P/B

5.22

P/Free Cash Flow

EPS

-0.98

Average EPS Est. Cur. Y

-0.59

EPS Next Y. (Est.)

-0.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.83

Return on Equity vs Sector %

-179.2

Return on Equity vs Industry %

-162.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

52.9

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=SANA 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=SANA 589 450 ]

◆ SANA Healthcare

$3.15

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

18/20

Pullback

17/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

46.1

Range 1M

54.3%

Sup Dist

0.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

10/30

Estimates

0/20

Inst/Vol

1/15

Options

8/10

EPS Yr

34.5%

EPS NY

-2.8%

52W%

34.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +167.6% upside

Quality

2/30

Valuation

16/30

Growth

6/25

Stability

4/10

LT Trend

3/5

Upside

+167.6%

Quality

Sana Biotechnology, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 142

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modified, stem cell derived pancreatic islet cell therapy, which is in preclinical trial for the treatment of type 1 diabetes; SG293 and SG299, a CD8-targeted fusosome for the treatment of B cell hematologic malignancies and B cell mediated autoimmune diseases. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.

[News_SANA _Stock]

stock quote shares SANA -Sana Biotechnology, Inc. Stock Price stock today

news today SANA -Sana Biotechnology, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SANA -Sana Biotechnology, Inc. yahoo finance google finance

stock history SANA -Sana Biotechnology, Inc. invest stock market

stock prices SANA premarket after hours

ticker SANA fair value insiders trading

SANA -Sana Biotechnology, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SANA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y